Abstract
Objective To study the clinical characteristics, diagnosis, treatments and prognostic features of granulocytic sarcoma (GS). Methods From October 2006 to August 2009, nine cases who diagnosed as GS in the First Affiliated Hospital of Soochow University were included into this study. The Clinical data of the nine patients were analyzed. The related literatures were reviewed as well. Results Two patients were diagnosed as primary GS. One case occurred before acute myeloid leukemia (AML). Three eases occurred concurrently with AML, and the other 3 cases were the manifestation of extramedullary relapse. All patients received resection and chemotherapy. Four patients received hematopoietic stem cell transplantation. Among the 9 patients, 2 cases failed to be followed up, 1 patient died after 30 months therapy, and the other 6 patients are still alive. Conclusion GS is a rarely diagnosed entity. Presenting symptoms varied depending on the different patient and tumor location. The diagnosis of GS depends on immunopathology. Chemotherapy is the proper treatment for GS. High dose of chemotherapy and hematopoietic stem cell transplantation might improve the prognosis of GS. Key words: granulocytic sarcoma; acute myeloid leukemia; Diagnosis; therapy
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Blood Transfusion and Hematology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
